Is there a way for men with azoospermia to undergo IVF in Hong Kong? Analysis of Hong Kong IVF options for azoospermia

Opening: Doctor's Decision Logic

Clinical Decision Starting Point: In a reproductive andrology clinic, when a semen analysis report shows "no sperm seen after centrifugation," the doctor's decision path does not directly initiate the IVF process. Instead, it first answers a core question — "What is the type of azoospermia?" The answer to this question determines all subsequent treatment directions.

1. Is there really a way for men with azoospermia to undergo IVF in Hong Kong?

There is a way, but the answer is not a uniform "yes" or "no"; it depends on the pathological type and cause of the azoospermia.

• Obstructive Azoospermia (OA): Sperm can be obtained via percutaneous epididymal sperm aspiration (PESA) or testicular sperm aspiration (TESA), followed by fertilization using ICSI (Intracytoplasmic Sperm Injection). There is a clear solution path for these patients.
• Non-obstructive Azoospermia (NOA): It is necessary to evaluate whether the testicles still have focal spermatogenic function. Some patients can find a small number of sperm through microdissection TESE (micro-TESE), followed by ICSI; if no sperm is found, donor sperm or adoption needs to be considered.

2. Root Causes of Azoospermia: Two Distinctly Different Pathological Mechanisms

To understand azoospermia, one must first distinguish between "impaired sperm production" and "impaired sperm expulsion."

1. Obstructive Azoospermia (OA) — Blocked ducts, but the factory is normal

The testicles have normal spermatogenic function, but the sperm ducts (epididymis, vas deferens, ejaculatory ducts) are blocked. Common causes include:

• Epididymal obstruction: Sequelae of infection (e.g., gonorrhea, chlamydia), or idiopathic obstruction.
• Vas deferens obstruction: History of vasectomy, inguinal surgery injury, congenital absence of the vas deferens.
• Ejaculatory duct obstruction: Often caused by cysts or inflammation.
• Congenital Bilateral Absence of the Vas Deferens (CBAVD): Associated with CFTR gene mutations, often accompanied by absence of the epididymal body.

2. Non-obstructive Azoospermia (NOA) — The factory itself has a problem

Testicular spermatogenic function is impaired or lost, with complex causes:

• Chromosomal abnormalities: Klinefelter syndrome (47,XXY), chromosomal translocations, inversions, etc.
• Y chromosome microdeletion (AZF deletion): Deletions in AZFa, AZFb, AZFc regions. AZFc deletion is the most common, and some patients may still have spermatogenic potential.
• Endocrine factors: Hypogonadotropic hypogonadism (low FSH, LH, testosterone).
• Gonadotoxic injury: Radiotherapy/chemotherapy, mumps orchitis, post-cryptorchidism surgery, varicocele, etc.
• Idiopathic spermatogenic disorder: Unknown cause, the most common type of NOA.

3. Reproductive Doctor's Decision Logic: Evaluation System and Key Indicators

When facing a patient with azoospermia, the doctor's evaluation is a step-by-step process, each step narrowing the diagnostic scope.

Step 1: Basic Tests (Determine the type)

Step 2: Diagnostic Aspiration (Identify obstruction site or spermatogenic status)

• Percutaneous Epididymal Sperm Aspiration (PESA): If sperm is found in the epididymis, obstructive azoospermia is essentially confirmed.
• Testicular Sperm Aspiration (TESA): If sperm is present in the testicle but not in the epididymis, it suggests the obstruction is in the epididymis or more proximally.
• Testicular Biopsy (Diagnostic): Used for NOA patients to assess spermatogenic status, but is now gradually being replaced by microdissection TESE.

4. Actual IVF Process in Hong Kong: Complete Path from Initial Consultation to Transfer

In Hong Kong, the IVF process for azoospermia is rigorously designed, emphasizing multidisciplinary collaboration (reproductive andrology, reproductive gynecology, embryology lab, genetic counseling).

Phase 1: Initial Consultation and Comprehensive Assessment (1-2 weeks)

• Male partner: Bring all previous test reports (semen analysis, hormones, karyotype, AZF, CFTR, etc.). The Hong Kong doctor will review and arrange supplementary tests (e.g., transrectal ultrasound, vasography, repeat hormone measurement).
• Female partner: Simultaneously undergo fertility assessment (AMH, FSH, LH, E2, antral follicle count, uterine cavity morphology assessment, infectious disease screening).
• Genetic counseling: If chromosomal abnormalities, AZF deletion, or CFTR mutations are present, genetic risk assessment is needed, and the necessity of PGT is discussed.

Phase 2: Protocol Formulation and Sperm Retrieval Surgery (1-2 months, synchronized with the female partner's cycle)

• OA patients: PESA/TESA is performed on the day of or 1-2 days before the female partner's egg retrieval. The surgery is done under local or general anesthesia, takes about 15-30 minutes, and the patient can be discharged after 1-2 hours of observation.
• NOA patients: It is recommended to undergo microdissection TESE surgery first before the female partner's egg retrieval cycle begins (as the surgery may take 2-4 hours, and confirmation of sperm retrieval is needed). Retrieved sperm is cryopreserved for ICSI on the day of egg retrieval. If no sperm is found, a donor sperm plan can be initiated promptly.

Phase 3: ICSI Fertilization and Embryo Culture (2-6 days)

• All sperm obtained through surgery are injected into the oocyte cytoplasm using ICSI to avoid fertilization failure due to insufficient sperm count or poor motility.
• Embryos are cultured to day 3 (cleavage stage) or day 5-6 (blastocyst stage). The transfer timing is determined based on embryo development and PGT requirements.
• If PGT (Preimplantation Genetic Testing) is performed, 5-10 cells are biopsied at the blastocyst stage to test for chromosomal aneuploidy (PGT-A) or specific monogenic diseases (PGT-M).

Phase 4: Transfer and Luteal Support (1-2 weeks)

• Transfer 1-2 high-quality blastocysts (if sufficient embryos are available). Routine luteal support with progesterone is given after transfer.
• Blood test for β-hCG is done 12-14 days after transfer to confirm pregnancy.

5. Timeline: How long does it take from initial consultation to pregnancy test?

6. Case Scenario Analysis: Real Paths in Different Situations

Scenario 1: Obstructive Azoospermia (OA) — Clear path, good prognosis

Background: 30-year-old male, semen analysis shows azoospermia, FSH 4.2 IU/L (normal), normal testicular volume, full epididymis. Normal chromosome karyotype, no AZF deletion.

Decision: Diagnosed with OA. PESA performed, yielding a large number of motile sperm. Female partner's AMH 3.8 ng/ml, normal ovarian function. Normal fertilization rate after ICSI was 78%, resulting in 5 blastocysts. Successful pregnancy after transferring 1 blastocyst.

Key Point: OA patients have the best prognosis. The core is to identify the obstruction site and effectively retrieve sperm. Female age is the main prognostic factor.

Scenario 2: Non-obstructive Azoospermia (NOA) with AZFc deletion — Conditional, requires genetic evaluation

Background: 34-year-old male, azoospermia, FSH 18.5 IU/L, testicular volume 10 ml. Normal chromosome karyotype, Y chromosome microdeletion shows AZFc deletion (sY254, sY255 deleted).

Decision: Diagnosed with NOA (AZFc deletion). Microdissection TESE (micro-TESE) performed, finding a small number of motile sperm in the right testicle. After ICSI, 3 blastocysts were obtained. PGT-A screening showed 2 with normal chromosomes. Pregnancy occurred after transferring 1.

Key Point: Patients with AZFc deletion still have a 40-60% chance of finding sperm, but male offspring will inherit the deletion. Genetic counseling is required, and related risks must be communicated. PGT-A can screen for aneuploidy but cannot change the fact of deletion inheritance.

Scenario 3: Klinefelter Syndrome (47,XXY) — Microdissection TESE offers a chance, requires psychological preparation

Background: 31-year-old male, height 183 cm, testicular volume 4 ml, azoospermia. FSH 32 IU/L, chromosome karyotype 47,XXY.

Decision: Diagnosed with Klinefelter syndrome. The doctor informed that the success rate of microdissection TESE is about 40-50%. The patient underwent surgery, and a small number of sperm were successfully found. After ICSI, 2 blastocysts were obtained. PGT-A showed 1 with normal chromosomes (46,XY or 46,XX). Pregnancy did not occur after transfer; a second transfer is planned.

Key Point: The success rate of microdissection TESE in Klinefelter syndrome patients is negatively correlated with age (higher success rate under 30). The rate of embryonic chromosomal abnormalities is high, so PGT-A is recommended. Psychological support is needed, as some patients may not find sperm.

7. Special Situation Management: Types of Azoospermia Requiring Special Attention

8. Frequently Asked Questions (6 Most Common Questions from Patients)

Question 1: What is the actual success rate of IVF for azoospermia?

The success rate primarily depends on the type of azoospermia, followed by the female partner's age. For OA patients undergoing PESA/TESA + ICSI, the clinical pregnancy rate is about 50-70% (female partner <35 years old). For NOA patients, the probability of finding sperm via microdissection TESE is 40-60%, and the ICSI pregnancy rate after finding sperm is similar to OA. When the female partner is >40 years old, the pregnancy rate drops significantly (<30%).

Question 2: What materials are needed for azoospermia IVF in Hong Kong?

• Male partner: Semen analysis reports (≥2 times), reproductive hormone results, chromosome karyotype, Y chromosome microdeletion report, CFTR gene report (if available), testicular/epididymal aspiration report (if available).
• Female partner: Fertility assessment report (AMH, hormone panel, ultrasound), infectious disease screening, past medical history records.
• Documents: Valid Mainland China Travel Permit for Hong Kong and Macau with valid endorsement, ID card, marriage certificate (required by some Hong Kong centers).
• Registration materials: Complete medical history questionnaire and sign informed consent forms as required by the center.

Question 3: Is microdissection TESE painful? Is hospitalization required?

Microdissection TESE is performed under general or local anesthesia, so there is no pain during the procedure. The post-operative incision is about 1-2 cm. Rest for 1-2 days is needed, and hospitalization is generally not required. Avoid strenuous activity and sexual intercourse for 1 week post-surgery; recovery is mostly complete after 1 week. Some patients may experience scrotal swelling or bruising, which usually subsides in 2-3 weeks.

Question 4: Is the genetic risk high for azoospermia IVF? Is PGT necessary?

Genetic risk is directly related to the cause. Chromosomal abnormalities (e.g., Klinefelter syndrome, translocations) and AZF deletions carry clear genetic risks, and PGT (PGT-A or PGT-M) is recommended to reduce the risk of inheritance in offspring. Obstructive azoospermia (e.g., epididymal obstruction) usually has no genetic risk, and PGT is not needed. CBAVD patients require CFTR gene testing and should consider PGT-M.

Question 5: What are the main differences between Hong Kong and Mainland China for azoospermia IVF?

Hong Kong has characteristics in the following areas: ① Extensive experience in microdissection TESE, with some centers performing a high annual volume of surgeries; ② Mature genetic counseling and PGT technology, with regulations supporting PGT except for sex selection; ③ Standardized donor sperm procedures, but with a waiting list (usually 6-18 months); ④ The legal system has relatively high tolerance for assisted reproduction, offering more options for complex cases. Some large reproductive centers in Mainland China also have equivalent technical capabilities, but overall, Hong Kong's internationalization and regulatory completeness provide supplementary options for some patients.

Question 6: What options are available if microdissection TESE fails to find sperm?

If microdissection TESE does not find sperm, there are three main paths: ① Donor sperm IVF: Use legally sourced donor sperm from Hong Kong or Mainland China for IVF or ICSI; ② Adoption: Adopt a child through legal channels; ③ Accepting a childless life: Some couples, after medical and psychological evaluation, choose to accept a life without children. It is recommended to understand and discuss these alternatives before microdissection TESE and be psychologically prepared.